Divestment programme curbs GSK in fourth quarter

11 February 2021 - Deborah Wilkes

Premium

Worldwide sales at GlaxoSmithKline (GSK) Consumer Healthcare dropped by 7% at constant exchange rates to GBP2.36 billion (USD3.31 billion) in the fourth quarter of 2020 following the recent divestment programme.

Click tags below for more information on topics:

GlaxoSmithKline COVID-19

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: